Gene Editing Cell Line Generation Service refers to a specialized scientific service provided by biotechnology companies and research institutions that involves the creation of cell lines with specific genetic modifications. These services utilize advanced gene editing technologies to precisely alter the DNA of cells, enabling researchers to study gene function, model diseases, develop drugs, and explore various aspects of cell biology.
The global Gene Editing Cell Line Generation Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Gene Editing Cell Line Generation Service Industry Forecast” looks at past sales and reviews total world Gene Editing Cell Line Generation Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Editing Cell Line Generation Service sales for 2023 through 2029. With Gene Editing Cell Line Generation Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Editing Cell Line Generation Service industry.
This Insight Report provides a comprehensive analysis of the global Gene Editing Cell Line Generation Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Editing Cell Line Generation Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Editing Cell Line Generation Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Editing Cell Line Generation Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Editing Cell Line Generation Service.
United States market for Gene Editing Cell Line Generation Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Gene Editing Cell Line Generation Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Gene Editing Cell Line Generation Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Gene Editing Cell Line Generation Service players cover Thermo Fisher Scientific, Merck, OriGene, Taconic Biosciences, Creative Bioarray, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Editing Cell Line Generation Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
CRISPR/Cas9
TALEN
Others
Segmentation by Application:
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
CRISPR/Cas9
TALEN
Others
Segmentation by Application:
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck
OriGene
Taconic Biosciences
Creative Bioarray
Horizon Discovery
Synthego
Applied Biological Materials
Cyagen
Cellecta
BiologicsCorp
Kyinno Bio
Applied StemCell
Creative Biogene
Porton Advanced
Cytosurge
AcceGen
System Biosciences
iXCells Biotechnologies
DefiniGEN
Alstem
BPS Bioscience
Creative Biolabs
Altogen Labs
Syd Labs
Lifeasible
Multispan
Crown Bioscience
genOway
WuXi Biologics
GenScript
Ubigene
Beyotime
Abace Biotechnology
Viewsolid Biotechnology
iGeneBio
VectorBuilder
BrainVTA

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Gene Editing Cell Line Generation Service Market Size 2019-2030 2.1.2 Gene Editing Cell Line Generation Service Market Size CAGR by Region (2019 VS 2023 VS 2030) 2.1.3 World Current & Future Analysis for Gene Editing Cell Line Generation Service by Country/Region, 2019, 2023 & 2030 2.2 Gene Editing Cell Line Generation Service Segment by Type 2.2.1 CRISPR/Cas9 2.2.2 TALEN 2.2.3 Others 2.3 Gene Editing Cell Line Generation Service Market Size by Type 2.3.1 Gene Editing Cell Line Generation Service Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Gene Editing Cell Line Generation Service Market Size Market Share by Type (2019-2024) 2.4 Gene Editing Cell Line Generation Service Segment by Application 2.4.1 Academic and Research Institutions 2.4.2 Pharmaceutical and Biotechnology Companies 2.5 Gene Editing Cell Line Generation Service Market Size by Application 2.5.1 Gene Editing Cell Line Generation Service Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Gene Editing Cell Line Generation Service Market Size Market Share by Application (2019-2024) 3 Gene Editing Cell Line Generation Service Market Size by Player 3.1 Gene Editing Cell Line Generation Service Market Size Market Share by Player 3.1.1 Global Gene Editing Cell Line Generation Service Revenue by Player (2019-2024) 3.1.2 Global Gene Editing Cell Line Generation Service Revenue Market Share by Player (2019-2024) 3.2 Global Gene Editing Cell Line Generation Service Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Gene Editing Cell Line Generation Service by Region 4.1 Gene Editing Cell Line Generation Service Market Size by Region (2019-2024) 4.2 Global Gene Editing Cell Line Generation Service Annual Revenue by Country/Region (2019-2024) 4.3 Americas Gene Editing Cell Line Generation Service Market Size Growth (2019-2024) 4.4 APAC Gene Editing Cell Line Generation Service Market Size Growth (2019-2024) 4.5 Europe Gene Editing Cell Line Generation Service Market Size Growth (2019-2024) 4.6 Middle East & Africa Gene Editing Cell Line Generation Service Market Size Growth (2019-2024) 5 Americas 5.1 Americas Gene Editing Cell Line Generation Service Market Size by Country (2019-2024) 5.2 Americas Gene Editing Cell Line Generation Service Market Size by Type (2019-2024) 5.3 Americas Gene Editing Cell Line Generation Service Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Gene Editing Cell Line Generation Service Market Size by Region (2019-2024) 6.2 APAC Gene Editing Cell Line Generation Service Market Size by Type (2019-2024) 6.3 APAC Gene Editing Cell Line Generation Service Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Gene Editing Cell Line Generation Service Market Size by Country (2019-2024) 7.2 Europe Gene Editing Cell Line Generation Service Market Size by Type (2019-2024) 7.3 Europe Gene Editing Cell Line Generation Service Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Gene Editing Cell Line Generation Service by Region (2019-2024) 8.2 Middle East & Africa Gene Editing Cell Line Generation Service Market Size by Type (2019-2024) 8.3 Middle East & Africa Gene Editing Cell Line Generation Service Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Gene Editing Cell Line Generation Service Market Forecast 10.1 Global Gene Editing Cell Line Generation Service Forecast by Region (2025-2030) 10.1.1 Global Gene Editing Cell Line Generation Service Forecast by Region (2025-2030) 10.1.2 Americas Gene Editing Cell Line Generation Service Forecast 10.1.3 APAC Gene Editing Cell Line Generation Service Forecast 10.1.4 Europe Gene Editing Cell Line Generation Service Forecast 10.1.5 Middle East & Africa Gene Editing Cell Line Generation Service Forecast 10.2 Americas Gene Editing Cell Line Generation Service Forecast by Country (2025-2030) 10.2.1 United States Market Gene Editing Cell Line Generation Service Forecast 10.2.2 Canada Market Gene Editing Cell Line Generation Service Forecast 10.2.3 Mexico Market Gene Editing Cell Line Generation Service Forecast 10.2.4 Brazil Market Gene Editing Cell Line Generation Service Forecast 10.3 APAC Gene Editing Cell Line Generation Service Forecast by Region (2025-2030) 10.3.1 China Gene Editing Cell Line Generation Service Market Forecast 10.3.2 Japan Market Gene Editing Cell Line Generation Service Forecast 10.3.3 Korea Market Gene Editing Cell Line Generation Service Forecast 10.3.4 Southeast Asia Market Gene Editing Cell Line Generation Service Forecast 10.3.5 India Market Gene Editing Cell Line Generation Service Forecast 10.3.6 Australia Market Gene Editing Cell Line Generation Service Forecast 10.4 Europe Gene Editing Cell Line Generation Service Forecast by Country (2025-2030) 10.4.1 Germany Market Gene Editing Cell Line Generation Service Forecast 10.4.2 France Market Gene Editing Cell Line Generation Service Forecast 10.4.3 UK Market Gene Editing Cell Line Generation Service Forecast 10.4.4 Italy Market Gene Editing Cell Line Generation Service Forecast 10.4.5 Russia Market Gene Editing Cell Line Generation Service Forecast 10.5 Middle East & Africa Gene Editing Cell Line Generation Service Forecast by Region (2025-2030) 10.5.1 Egypt Market Gene Editing Cell Line Generation Service Forecast 10.5.2 South Africa Market Gene Editing Cell Line Generation Service Forecast 10.5.3 Israel Market Gene Editing Cell Line Generation Service Forecast 10.5.4 Turkey Market Gene Editing Cell Line Generation Service Forecast 10.6 Global Gene Editing Cell Line Generation Service Forecast by Type (2025-2030) 10.7 Global Gene Editing Cell Line Generation Service Forecast by Application (2025-2030) 10.7.1 GCC Countries Market Gene Editing Cell Line Generation Service Forecast 11 Key Players Analysis 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Information 11.1.2 Thermo Fisher Scientific Gene Editing Cell Line Generation Service Product Offered 11.1.3 Thermo Fisher Scientific Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Thermo Fisher Scientific Main Business Overview 11.1.5 Thermo Fisher Scientific Latest Developments 11.2 Merck 11.2.1 Merck Company Information 11.2.2 Merck Gene Editing Cell Line Generation Service Product Offered 11.2.3 Merck Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Merck Main Business Overview 11.2.5 Merck Latest Developments 11.3 OriGene 11.3.1 OriGene Company Information 11.3.2 OriGene Gene Editing Cell Line Generation Service Product Offered 11.3.3 OriGene Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 OriGene Main Business Overview 11.3.5 OriGene Latest Developments 11.4 Taconic Biosciences 11.4.1 Taconic Biosciences Company Information 11.4.2 Taconic Biosciences Gene Editing Cell Line Generation Service Product Offered 11.4.3 Taconic Biosciences Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Taconic Biosciences Main Business Overview 11.4.5 Taconic Biosciences Latest Developments 11.5 Creative Bioarray 11.5.1 Creative Bioarray Company Information 11.5.2 Creative Bioarray Gene Editing Cell Line Generation Service Product Offered 11.5.3 Creative Bioarray Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Creative Bioarray Main Business Overview 11.5.5 Creative Bioarray Latest Developments 11.6 Horizon Discovery 11.6.1 Horizon Discovery Company Information 11.6.2 Horizon Discovery Gene Editing Cell Line Generation Service Product Offered 11.6.3 Horizon Discovery Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Horizon Discovery Main Business Overview 11.6.5 Horizon Discovery Latest Developments 11.7 Synthego 11.7.1 Synthego Company Information 11.7.2 Synthego Gene Editing Cell Line Generation Service Product Offered 11.7.3 Synthego Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Synthego Main Business Overview 11.7.5 Synthego Latest Developments 11.8 Applied Biological Materials 11.8.1 Applied Biological Materials Company Information 11.8.2 Applied Biological Materials Gene Editing Cell Line Generation Service Product Offered 11.8.3 Applied Biological Materials Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Applied Biological Materials Main Business Overview 11.8.5 Applied Biological Materials Latest Developments 11.9 Cyagen 11.9.1 Cyagen Company Information 11.9.2 Cyagen Gene Editing Cell Line Generation Service Product Offered 11.9.3 Cyagen Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Cyagen Main Business Overview 11.9.5 Cyagen Latest Developments 11.10 Cellecta 11.10.1 Cellecta Company Information 11.10.2 Cellecta Gene Editing Cell Line Generation Service Product Offered 11.10.3 Cellecta Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Cellecta Main Business Overview 11.10.5 Cellecta Latest Developments 11.11 BiologicsCorp 11.11.1 BiologicsCorp Company Information 11.11.2 BiologicsCorp Gene Editing Cell Line Generation Service Product Offered 11.11.3 BiologicsCorp Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 BiologicsCorp Main Business Overview 11.11.5 BiologicsCorp Latest Developments 11.12 Kyinno Bio 11.12.1 Kyinno Bio Company Information 11.12.2 Kyinno Bio Gene Editing Cell Line Generation Service Product Offered 11.12.3 Kyinno Bio Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 Kyinno Bio Main Business Overview 11.12.5 Kyinno Bio Latest Developments 11.13 Applied StemCell 11.13.1 Applied StemCell Company Information 11.13.2 Applied StemCell Gene Editing Cell Line Generation Service Product Offered 11.13.3 Applied StemCell Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.13.4 Applied StemCell Main Business Overview 11.13.5 Applied StemCell Latest Developments 11.14 Creative Biogene 11.14.1 Creative Biogene Company Information 11.14.2 Creative Biogene Gene Editing Cell Line Generation Service Product Offered 11.14.3 Creative Biogene Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.14.4 Creative Biogene Main Business Overview 11.14.5 Creative Biogene Latest Developments 11.15 Porton Advanced 11.15.1 Porton Advanced Company Information 11.15.2 Porton Advanced Gene Editing Cell Line Generation Service Product Offered 11.15.3 Porton Advanced Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.15.4 Porton Advanced Main Business Overview 11.15.5 Porton Advanced Latest Developments 11.16 Cytosurge 11.16.1 Cytosurge Company Information 11.16.2 Cytosurge Gene Editing Cell Line Generation Service Product Offered 11.16.3 Cytosurge Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.16.4 Cytosurge Main Business Overview 11.16.5 Cytosurge Latest Developments 11.17 AcceGen 11.17.1 AcceGen Company Information 11.17.2 AcceGen Gene Editing Cell Line Generation Service Product Offered 11.17.3 AcceGen Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.17.4 AcceGen Main Business Overview 11.17.5 AcceGen Latest Developments 11.18 System Biosciences 11.18.1 System Biosciences Company Information 11.18.2 System Biosciences Gene Editing Cell Line Generation Service Product Offered 11.18.3 System Biosciences Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.18.4 System Biosciences Main Business Overview 11.18.5 System Biosciences Latest Developments 11.19 iXCells Biotechnologies 11.19.1 iXCells Biotechnologies Company Information 11.19.2 iXCells Biotechnologies Gene Editing Cell Line Generation Service Product Offered 11.19.3 iXCells Biotechnologies Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.19.4 iXCells Biotechnologies Main Business Overview 11.19.5 iXCells Biotechnologies Latest Developments 11.20 DefiniGEN 11.20.1 DefiniGEN Company Information 11.20.2 DefiniGEN Gene Editing Cell Line Generation Service Product Offered 11.20.3 DefiniGEN Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.20.4 DefiniGEN Main Business Overview 11.20.5 DefiniGEN Latest Developments 11.21 Alstem 11.21.1 Alstem Company Information 11.21.2 Alstem Gene Editing Cell Line Generation Service Product Offered 11.21.3 Alstem Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.21.4 Alstem Main Business Overview 11.21.5 Alstem Latest Developments 11.22 BPS Bioscience 11.22.1 BPS Bioscience Company Information 11.22.2 BPS Bioscience Gene Editing Cell Line Generation Service Product Offered 11.22.3 BPS Bioscience Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.22.4 BPS Bioscience Main Business Overview 11.22.5 BPS Bioscience Latest Developments 11.23 Creative Biolabs 11.23.1 Creative Biolabs Company Information 11.23.2 Creative Biolabs Gene Editing Cell Line Generation Service Product Offered 11.23.3 Creative Biolabs Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.23.4 Creative Biolabs Main Business Overview 11.23.5 Creative Biolabs Latest Developments 11.24 Altogen Labs 11.24.1 Altogen Labs Company Information 11.24.2 Altogen Labs Gene Editing Cell Line Generation Service Product Offered 11.24.3 Altogen Labs Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.24.4 Altogen Labs Main Business Overview 11.24.5 Altogen Labs Latest Developments 11.25 Syd Labs 11.25.1 Syd Labs Company Information 11.25.2 Syd Labs Gene Editing Cell Line Generation Service Product Offered 11.25.3 Syd Labs Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.25.4 Syd Labs Main Business Overview 11.25.5 Syd Labs Latest Developments 11.26 Lifeasible 11.26.1 Lifeasible Company Information 11.26.2 Lifeasible Gene Editing Cell Line Generation Service Product Offered 11.26.3 Lifeasible Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.26.4 Lifeasible Main Business Overview 11.26.5 Lifeasible Latest Developments 11.27 Multispan 11.27.1 Multispan Company Information 11.27.2 Multispan Gene Editing Cell Line Generation Service Product Offered 11.27.3 Multispan Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.27.4 Multispan Main Business Overview 11.27.5 Multispan Latest Developments 11.28 Crown Bioscience 11.28.1 Crown Bioscience Company Information 11.28.2 Crown Bioscience Gene Editing Cell Line Generation Service Product Offered 11.28.3 Crown Bioscience Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.28.4 Crown Bioscience Main Business Overview 11.28.5 Crown Bioscience Latest Developments 11.29 genOway 11.29.1 genOway Company Information 11.29.2 genOway Gene Editing Cell Line Generation Service Product Offered 11.29.3 genOway Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.29.4 genOway Main Business Overview 11.29.5 genOway Latest Developments 11.30 WuXi Biologics 11.30.1 WuXi Biologics Company Information 11.30.2 WuXi Biologics Gene Editing Cell Line Generation Service Product Offered 11.30.3 WuXi Biologics Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.30.4 WuXi Biologics Main Business Overview 11.30.5 WuXi Biologics Latest Developments 11.31 GenScript 11.31.1 GenScript Company Information 11.31.2 GenScript Gene Editing Cell Line Generation Service Product Offered 11.31.3 GenScript Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.31.4 GenScript Main Business Overview 11.31.5 GenScript Latest Developments 11.32 Ubigene 11.32.1 Ubigene Company Information 11.32.2 Ubigene Gene Editing Cell Line Generation Service Product Offered 11.32.3 Ubigene Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.32.4 Ubigene Main Business Overview 11.32.5 Ubigene Latest Developments 11.33 Beyotime 11.33.1 Beyotime Company Information 11.33.2 Beyotime Gene Editing Cell Line Generation Service Product Offered 11.33.3 Beyotime Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.33.4 Beyotime Main Business Overview 11.33.5 Beyotime Latest Developments 11.34 Abace Biotechnology 11.34.1 Abace Biotechnology Company Information 11.34.2 Abace Biotechnology Gene Editing Cell Line Generation Service Product Offered 11.34.3 Abace Biotechnology Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.34.4 Abace Biotechnology Main Business Overview 11.34.5 Abace Biotechnology Latest Developments 11.35 Viewsolid Biotechnology 11.35.1 Viewsolid Biotechnology Company Information 11.35.2 Viewsolid Biotechnology Gene Editing Cell Line Generation Service Product Offered 11.35.3 Viewsolid Biotechnology Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.35.4 Viewsolid Biotechnology Main Business Overview 11.35.5 Viewsolid Biotechnology Latest Developments 11.36 iGeneBio 11.36.1 iGeneBio Company Information 11.36.2 iGeneBio Gene Editing Cell Line Generation Service Product Offered 11.36.3 iGeneBio Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.36.4 iGeneBio Main Business Overview 11.36.5 iGeneBio Latest Developments 11.37 VectorBuilder 11.37.1 VectorBuilder Company Information 11.37.2 VectorBuilder Gene Editing Cell Line Generation Service Product Offered 11.37.3 VectorBuilder Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.37.4 VectorBuilder Main Business Overview 11.37.5 VectorBuilder Latest Developments 11.38 BrainVTA 11.38.1 BrainVTA Company Information 11.38.2 BrainVTA Gene Editing Cell Line Generation Service Product Offered 11.38.3 BrainVTA Gene Editing Cell Line Generation Service Revenue, Gross Margin and Market Share (2019-2024) 11.38.4 BrainVTA Main Business Overview 11.38.5 BrainVTA Latest Developments 12 Research Findings and Conclusion